CIDNI is extremely proud of our team on the 7 abstracts that have been accepted for oral presentations at the 57thUnion World Conference on Lung Health in Rio de Janeiro, Brazil.

  1. Anemia Incidence, Timing, and Resolution in BringBPaL2Me Trial: A Blinded Interim Safety Analysis of Nurse or Physician Management in South African Primary Health Care Clinics
    Y Kadernani, K Lowensen, G Clemens, C Budhathoki, N Mlandu, N Ndjeka, D Evans, & JE Farley
  2. Culture Conversion in RR-TB Patients on BPaL-L Despite Baseline Bedaquiline Resistance in South African Primary Health Care Settings: Findings from the BringBPaL2Me trial
    Y Kadernani, SV Omar, F Ismail, K Lowensen, G Clemens, C Budhathoki, N Mlandu, S Charalambous, Y van der Heijden, N Ndjeka, D Evans, & JE Farley
  3. Decentralization and geographic access to drug-resistant tuberculosis treatment in South Africa: evidence from the Bring BPaL2Me trial
    RBV Tavares, K Lowensen, Y Kadernani, KN Mlandu, RA Arcêncio, N Ndjeka, D Evans, & JE Farley
  4. Persistent urban high-risk areas and emerging inland clusters of drug-resistant tuberculosis in São Paulo state, Brazil
    RBV Tavares, YM Alves, N Zini, AF Tártaro, MEP Pelodan, DdM. Pinheiro, LKLd Santos, MGBFd Faria, MAP Popolin, JGdA Ballestero, JE Farley, & RA Arcêncio
  5. Pregnancy during BPaL-L treatment in a drug-resistant tuberculosis clinical trial: A case series from the BPaL2Me Trial
    E Di Giacomo, K Lowensen, Y Kadernani, N Makubalo, P Howell, D Evans, N Ndjeka, & JE Farley
  6. Transfer to Higher Level of Care During BPaL-Containing Treatment in South African Primary Health Care Clinics: A Blinded Interim Safety Analysis from BringBPaL2Me Trial
    JE Farley, K Lowensen, Y Kadernani, G Clemens, N Mlandu, D Evans, N Ndjeka
  7. Urine-detected substance use and its spatial distribution during drug-resistant tuberculosis treatment in the Bring BPaL2Me trial, South Africa
    RBV Tavares, JE Farley, K Lowensen, Y Kadernani, KN Mlandu, RA Arcêncio, N Ndjeka, D Evans, & A Bergman

Additionally, we had an acceptance for a poster presentation as well:

Coping strategies and financial impact of DR-TB treatment: interim analysis from the Bring BPaL2Me trial

Hirasen K, Ramushu C, Kadernani Y, Lowensen K, Mlandu K, Ndjeka N, Farley JE, & Evans D.

Please look for these topics in the agenda.